Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 2/20 | 0.31 |
| ▸ | HTR2C | P28335 | 2/20 | 0.31 |
| ▸ | HTR2B | P41595 | 2/20 | 0.31 |
| ▸ | RECQL | P46063 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5556834 | 1.00 | HTR2A (0.31) | HTR2AHTR2CHTR2BRECQLCYP3A4 | |
| SCHEMBL7680409 | 1.00 | HTR2A (0.31) | HTR2AHTR2CHTR2BRECQLCYP3A4 | |
| SCHEMBL1879917 | 1.00 | HTR2A (0.31) | HTR2AHTR2CHTR2BRECQLCYP3A4 | |
| SCHEMBL10939471 | 0.88 | CYP3A4 (0.33) | HTR2CCYP3A4TDP1 | |
| SCHEMBL11048802 | 0.88 | CYP3A4 (0.33) | HTR2CCYP3A4TDP1 | |
| SCHEMBL17200747 | 0.87 | ACHE (0.40) | CYP3A4TDP1 | |
| SCHEMBL10709566 | 0.83 | TRPV6 (0.39) | HTR2AHTR2CHTR2BTDP1 | |
| SCHEMBL10939481 | 0.83 | CA4 (0.39) | CYP3A4TDP1 | |
| SCHEMBL36560 | 0.82 | ALDH1A1 (0.40) | HTR2CCYP3A4TDP1 | |
| Boric Acid SCHEMBL11048797 | 0.81 | CA4 (0.38) | TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 209 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116113256-B | Precursor material of electron injection layer, preparation method and application thereof | 宁波杭州湾新材料研究院 | 2025-01-07 | — | — | CN | claimed |
| US-20240309130-A1 | COMPOSITION BASED ON (METH)ACRYLATE MONOMERS | BOSTIK SA (FR) | 2024-09-19 | — | — | US | claimed |
| US-20240309129-A1 | COMPOSITION BASED ON (METH)ACRYLATE MONOMERS | BOSTIK SA (FR) | 2024-09-19 | — | — | US | claimed |
| EP-4370563-A1 | COMPOSITION BASED ON (METH)ACRYLATE MONOMERS | Bostik SA (FR) | 2024-05-22 | — | — | EP | claimed |
| EP-4370564-A1 | COMPOSITION BASED ON (METH)ACRYLATE MONOMERS | Bostik SA (FR) | 2024-05-22 | — | — | EP | claimed |
| CN-117980348-A | Compositions based on (meth) acrylate monomers | 博斯蒂克股份公司 | 2024-05-03 | — | — | CN | claimed |
| CN-117940467-A | Compositions based on (meth) acrylate monomers | 博斯蒂克股份公司 | 2024-04-26 | — | — | CN | claimed |
| CN-116113256-A | Precursor material of electron injection layer, preparation method and application thereof | 宁波杭州湾新材料研究院 | 2023-05-12 | — | — | CN | claimed |
| WO-2023285759-A1 | COMPOSITION BASED ON (METH)ACRYLATE MONOMERS | BOSTIK SA (FR) | 2023-01-19 | — | — | WO | claimed |
| WO-2023285760-A1 | COMPOSITION BASED ON (METH)ACRYLATE MONOMERS | BOSTIK SA (FR) | 2023-01-19 | — | — | WO | claimed |
| CN-110407753-B | Method for synthesizing pentaarylimidazolium salt from diaryl iodonium salt and imidazole | 桂林理工大学 | 2022-08-09 | — | — | CN | claimed |
| EP-2283914-A1 | Membrane surface modification by radiation-induced polymerization | Millipore Corporation (US) | 2011-02-16 | — | — | EP | claimed |
| US-7717273-B2 | Membrane surface modification by radiation-induced polymerization | MILLIPORE CORPORATION (US) | 2010-05-18 | — | — | US | claimed |
| US-20070272607-A1 | Membrane surface modification by radiation-induced polymerization | MILLIPORE CORPORATION (US) | 2007-11-29 | — | — | US | claimed |
| EP-1859855-A1 | Membrane surface modification by radiation-induced polymerization | MILLIPORE CORPORATION (US) | 2007-11-28 | — | — | EP | claimed |
| EP-0224730-B1 | ANAEROBIC ADHESIVE COMPOSITIONS | National Starch and Chemical Investment Holding Corporation (US) | 1992-03-04 | — | — | EP | claimed |
| EP-0224730-A2 | Anaerobic adhesive compositions | National Starch and Chemical Investment Holding Corporation (US) | 1987-06-10 | — | — | EP | claimed |
| US-4656229-A | CURABLE ACRYLATE, DIARYL IODINIUM SALT CATALYST AND ALDEHYDE-AMINE CONDENSATION PRODUCT AS ACTIVATOR; STORAGE STABILITY | NATIONAL STARCH AND CHEMICAL CORPORATION (US) | 1987-04-07 | — | — | US | claimed |
| US-12460049-B2 | Azide-functionalized copolymers | SUSOS AG (CH) | 2025-11-04 | — | — | US | disclosed |
| US-4058401-A | Photocurable compositions containing group via aromatic onium salts | GENERAL ELECTRIC COMPANY (US) | 1977-11-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12460049-B2 | Azide-functionalized copolymers | PAM, MPI, MSN | HTR2A 1487/4885HTR2C 1458/4885HTR2B 815/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.